Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome
NCT ID: NCT05521295
Last Updated: 2022-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3600 participants
OBSERVATIONAL
2022-09-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome and Transcriptome
NCT05545631
Effect of Reproductive Tract Microbiota on Pregnancy Outcome in IVF/ICSI
NCT04293068
Vaginal Microbiome and IVF Pregnancy Outcome
NCT05150639
Whether Vaginal Microbiota Affects Pregnancy Outcomes After Embryo Transfer
NCT06296615
The Human Microbiome and IVF Outcomes
NCT03637777
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conception positive
serum human chorionic gonadotropin ≥10 mIU/mL
no intervention
no intervention in this study
Conception negative
serum human chorionic gonadotropin \<10 mIU/mL
no intervention
no intervention in this study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention in this study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Female age: 20-45 years old;
3. Single frozen-thawed blastocyst Transferred
4. Endometrial thickness ≥7mm on the day of luteal transformation
5. Written informed consent.
Exclusion Criteria
2. Untreated hyperprolactinemia, thyroid disease, adrenal disease
3. Antibiotic use within the past 7 days;
4. Current or recent (within 3 months) drug abuse, including alcohol and tobacco;
5. Refused or unable to comply with protocol requirements;
6. Participation in any experimental drug study within 60 days prior to screening.
20 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Institutes of Life Science, Chinese Academy of Sciences
UNKNOWN
Shengjing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiuxia Wang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiuxia Wang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Center of Reproductive Medicine, Shengjing Hospital of China Medical University
Donghua Cao, Doctor
Role: PRINCIPAL_INVESTIGATOR
Shengyang Jinghua Hospital Co.,Ltd
Sufen Cai, Doctor
Role: PRINCIPAL_INVESTIGATOR
Reproductive and Genetic Hospital of CITIC-Xiangya
Yanwen Xu, Doctor
Role: PRINCIPAL_INVESTIGATOR
Reproductive Medical Center, the First Affiliated Hospital, Sun Yat-sen University
Hong Li, Doctor
Role: PRINCIPAL_INVESTIGATOR
Center of reproduction and genetics Suzhou Municipal Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiuxia Wang
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Shengjing Hospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.